{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:57:09Z","timestamp":1790575029438,"version":"4.1.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Estimated plasma volume status (ePVS) and neutrophil-to-lymphocyte ratio (NLR) are novel biomarkers reflecting hemodynamic load and systemic inflammatory immune status, respectively. This study aimed to explore the prognostic value of combined ePVS and NLR for cardiovascular mortality in patients with heart failure (HF) complicating acute myocardial infarction (AMI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational study consecutively enrolled patients diagnosed with AMI complicated by HF at Putian University Affiliated Hospital from January 2020 to June 2024. Admission hemoglobin and hematocrit levels were used to calculate ePVS, while routine blood test parameters were applied to determine NLR. The primary endpoint was cardiovascular mortality within two years after AMI. Cox proportional hazards regression models were constructed to analyze the associations of ePVS and NLR with clinical endpoints. The predictive efficacy of single and combined ePVS and NLR was comprehensively evaluated using the area under the receiver operating characteristic curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 2046 patients were ultimately included. During a mean follow-up of 819 days, endpoint events occurred in 14.90% of the study population. Univariate Cox regression analysis demonstrated that ePVS served as a strong risk factor for cardiovascular mortality (HR\u2009=\u20091.571, 95% CI: 1.502\u20131.642,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). After adjusting for age, diabetes mellitus, hypertension, atrial fibrillation, and NLR, both ePVS (HR\u2009=\u20091.436, 95% CI: 1.370\u20131.505,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) and NLR (HR\u2009=\u20091.330, 95% CI: 1.258\u20131.406,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001) remained independent predictors of cardiovascular mortality. The combined predictive model integrating ePVS and NLR exhibited significantly superior predictive performance compared with either biomarker alone (AUC: 0.794 for ePVS vs. 0.891 for ePVS\u2009+\u2009NLR,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). Both NRI and IDI analyses further verified the significant improvement in predictive accuracy of the combined model (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ePVS and NLR represent valuable prognostic biomarkers for cardiovascular mortality in AMI patients. The combination of ePVS and NLR significantly improves predictive performance and facilitates precise risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1948520","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:44:09Z","timestamp":1790574249000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of combined estimated plasma volume status and neutrophil-to-lymphocyte ratio for cardiovascular mortality in patients with acute myocardial infarction with heart failure"],"prefix":"10.3389","volume":"13","author":[{"given":"Caizhi","family":"Dai","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Chen","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuting","family":"Chen","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Lin","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Putian University","place":["Putian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/ejhf.2961","article-title":"Heart failure after myocardial infarction: glass emptier than full","volume":"25","author":"Harrington","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"B2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","article-title":"Post-myocardial infarction heart failure","volume":"6","author":"Bahit","year":"2018","journal-title":"JACC Heart Fail"},{"key":"B3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1083\/jcb.201101100","article-title":"The cell biology of disease: cellular mechanisms of cardiomyopathy","volume":"194","author":"Harvey","year":"2011","journal-title":"J Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s11886-000-0007-4","article-title":"The myocardial matrix and the development and progression of ventricular remodeling","volume":"2","author":"Sackner-Bernstein","year":"2000","journal-title":"Curr Cardiol Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"115572","DOI":"10.1016\/j.intimp.2025.115572","article-title":"TRIM21 exacerbates hypoxia-induced cardiomyocyte pyroptosis through GSDMD ubiquitination in post-myocardial infarction heart failure","volume":"166","author":"Lin","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3000605231202573","DOI":"10.1177\/03000605231202573","article-title":"Mechanism of heart failure after myocardial infarction","volume":"51","author":"Jiang","year":"2023","journal-title":"J Int Med Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/ijms23052728","article-title":"Non-coding RNAs: Prevention, Diagnosis, and treatment in myocardial ischemia-reperfusion injury","volume":"23","author":"Marinescu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1002\/ejhf.3401","article-title":"Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: size matters","volume":"26","author":"de La Espriella","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11506","DOI":"10.1038\/s41598-021-91082-w","article-title":"Predictive value of neutrophil to lymphocyte ratio and red cell distribution width on death for ST segment elevation myocardial infarction","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1069864","DOI":"10.3389\/fcvm.2023.1069864","article-title":"Effect of estimated plasma volume status and left atrial diameter on prognosis of patients with acute heart failure","volume":"10","author":"Chen","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1002\/ehf2.14912","article-title":"Prognostic value of estimated plasma volume status at discharge in acute myocardial infarction","volume":"11","author":"Nogi","year":"2024","journal-title":"ESC Heart Fail"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1499378","DOI":"10.3389\/fcvm.2025.1499378","article-title":"Estimated plasma volume status as a prognostic indicator in myocardial infarction and heart failure: insights from the MIMIC-IV database","volume":"12","author":"Luo","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/eurheartj\/ehaf289","article-title":"Acute coronary syndromes: mechanisms, challenges, and new opportunities","volume":"46","author":"Kraler","year":"2025","journal-title":"Eur Heart J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S0140-6736(25)01394-7","article-title":"Prevention of heart failure after acute myocardial infarction","volume":"406","author":"Udell","year":"2025","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"100748","DOI":"10.1016\/j.ijcha.2021.100748","article-title":"Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction","volume":"33","author":"Kawai","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.3390\/antiox12111944","article-title":"Inflammation in myocardial ischemia\/reperfusion injury: underlying mechanisms and therapeutic potential","volume":"12","author":"Francisco","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1439650","DOI":"10.3389\/fcvm.2025.1439650","article-title":"Prognostic value of inflammatory markers for all-cause mortality in patients with acute myocardial infarction in the coronary care unit: a retrospective study based on MIMIC-IV database","volume":"12","author":"Cao","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacol Ther"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1948520\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:44:09Z","timestamp":1790574249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1948520\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":21,"alternative-id":["10.3389\/fcvm.2026.1948520"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1948520","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1948520"}}